FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,999 | +1418.4% | 89,189 | +1028.5% | 0.00% | – |
| Q2 2023 | $26,080 | +435.1% | 7,903 | +362.2% | 0.00% | – |
| Q1 2023 | $4,874 | -61.8% | 1,710 | -2.5% | 0.00% | – |
| Q4 2022 | $12,762 | -20.2% | 1,753 | -8.7% | 0.00% | – |
| Q3 2022 | $16,000 | -11.1% | 1,920 | -48.7% | 0.00% | – |
| Q2 2022 | $18,000 | -97.4% | 3,740 | -87.2% | 0.00% | – |
| Q1 2022 | $691,000 | -3.4% | 29,228 | -27.7% | 0.00% | – |
| Q4 2021 | $715,000 | +247.1% | 40,433 | +452.7% | 0.00% | – |
| Q3 2021 | $206,000 | +182.2% | 7,315 | +5.7% | 0.00% | – |
| Q2 2021 | $73,000 | +247.6% | 6,919 | +297.4% | 0.00% | – |
| Q1 2021 | $21,000 | -50.0% | 1,741 | -51.5% | 0.00% | – |
| Q4 2020 | $42,000 | +740.0% | 3,592 | +422.9% | 0.00% | – |
| Q3 2020 | $5,000 | -84.4% | 687 | -60.4% | 0.00% | – |
| Q2 2020 | $32,000 | -27.3% | 1,737 | -52.8% | 0.00% | – |
| Q1 2020 | $44,000 | +193.3% | 3,679 | +303.4% | 0.00% | – |
| Q4 2019 | $15,000 | +650.0% | 912 | +281.6% | 0.00% | – |
| Q3 2019 | $2,000 | – | 239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |